Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005412
Filing Date
2020-05-06
Accepted
2020-05-06 16:18:41
Documents
66
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q axgn-20200506x10q.htm   iXBRL 10-Q 1155945
2 EX-31.1 axgn-20200331xex31d1.htm EX-31.1 18957
3 EX-31.2 axgn-20200331xex31d2.htm EX-31.2 19258
4 EX-32 axgn-20200331xex32.htm EX-32 15057
  Complete submission text file 0001558370-20-005412.txt   5468480

Data Files

Seq Description Document Type Size
5 EX-101.SCH axgn-20200506.xsd EX-101.SCH 45816
6 EX-101.CAL axgn-20200506_cal.xml EX-101.CAL 56401
7 EX-101.DEF axgn-20200506_def.xml EX-101.DEF 109717
8 EX-101.LAB axgn-20200506_lab.xml EX-101.LAB 413116
9 EX-101.PRE axgn-20200506_pre.xml EX-101.PRE 276656
59 EXTRACTED XBRL INSTANCE DOCUMENT axgn-20200506x10q_htm.xml XML 997423
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36046 | Film No.: 20852864
SIC: 3845 Electromedical & Electrotherapeutic Apparatus